A CAR with NKG2D fused to the T cell receptor ζ-chain expressed in NK cells demonstrated cytotoxicity against myeloid-derived suppressor cells and improved antitumor activity against neuroblastoma [148]. The gene discussed is KLRK1; the disease is neuroblastoma.